Xiaojuan Xu
Kaifeng, 475004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Inhibition of LDHA promotes GSDME-dependent pyroptosis by activating RIG-I-like receptor signaling.
Journal: Apoptosis : an international journal on programmed cell death
Published: September 17, 2025
Polyamine-modified naphthalimide derivative 9C inhibits colorectal cancer through ROS-mediated ER stress, migration and invasion.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: August 03, 2024
Reactive Oxygen Species Mediate 6c-Induced Mitochondrial and Lysosomal Dysfunction, Autophagic Cell Death, and DNA Damage in Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: August 22, 2021
Suppression of oxidative phosphorylation and IDH2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantrone.
Journal: Cancer letters
Published: April 16, 2021
Identification of molecular anti-metastasis mechanisms of lycorine in colorectal cancer by RNA-seq analysis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 14, 2020
The Role of p53-Mediated Signaling in the Therapeutic Response of Colorectal Cancer to 9F, a Spermine-Modified Naphthalene Diimide Derivative.
Journal: Cancers
Published: December 30, 2019
Synthesis and biological evaluation of novel asymmetric naphthalene diimide derivatives as anticancer agents depending on ROS generation.
Journal: MedChemComm
Published: May 22, 2018
Synthesis and biological evaluation of naphthalimide-polyamine conjugates modified by alkylation as anticancer agents through p53 pathway.
Journal: Bioorganic chemistry
Published: October 12, 2017
Design, Synthesis, and Biological Evaluation of Mitochondria-Targeted Flavone-Naphthalimide-Polyamine Conjugates with Antimetastatic Activity.
Journal: Journal of medicinal chemistry
Published: February 09, 2017
Design, Synthesis and Evaluation of Naphthalimide Derivatives as Potential Anticancer Agents for Hepatocellular Carcinoma.
Journal: Molecules (Basel, Switzerland)
Published: January 13, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026